药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Arbutamine
Droxidopa
Flibanserin may increase the hypertensive activities of Droxidopa.
Arbutamine
Naxitamab
The risk or severity of hypertension can be increased when Flibanserin is combined with Naxitamab.
Arbutamine
Loxoprofen
The risk or severity of hypertension can be increased when Flibanserin is combined with Loxoprofen.
Arbutamine
Selpercatinib
The risk or severity of hypertension can be increased when Flibanserin is combined with Selpercatinib.
Arbutamine
Levosalbutamol
The risk or severity of hypertension can be increased when Flibanserin is combined with Levosalbutamol.
Arbutamine
Siponimod
The risk or severity of hypertension can be increased when Flibanserin is combined with Siponimod.
Arbutamine
Propacetamol
The risk or severity of hypertension can be increased when Flibanserin is combined with Propacetamol.
Arbutamine
Tolfenamic acid
The risk or severity of hypertension can be increased when Flibanserin is combined with Tolfenamic acid.
Arbutamine
Vilanterol
The risk or severity of hypertension can be increased when Flibanserin is combined with Vilanterol.
Arbutamine
Parecoxib
The risk or severity of hypertension can be increased when Flibanserin is combined with Parecoxib.
Arbutamine
Nylidrin
The risk or severity of hypertension can be increased when Flibanserin is combined with Nylidrin.
Arbutamine
Zomepirac
The risk or severity of hypertension can be increased when Zomepirac is combined with Flibanserin.
Arbutamine
Metamizole
The risk or severity of hypertension can be increased when Metamizole is combined with Flibanserin.
Arbutamine
Nimesulide
The risk or severity of hypertension can be increased when Nimesulide is combined with Flibanserin.
Arbutamine
Etoricoxib
The risk or severity of hypertension can be increased when Etoricoxib is combined with Flibanserin.
Arbutamine
Quinoline Yellow WS
The risk or severity of hypertension can be increased when Flibanserin is combined with Quinoline Yellow WS.
Arbutamine
NS-398
The risk or severity of hypertension can be increased when Flibanserin is combined with NS-398.
Arbutamine
SC-236
The risk or severity of hypertension can be increased when Flibanserin is combined with SC-236.
Arbutamine
Deoxyepinephrine
The risk or severity of hypertension can be increased when Flibanserin is combined with Deoxyepinephrine.
Arbutamine
Imidazole salicylate
The risk or severity of hypertension can be increased when Flibanserin is combined with Imidazole salicylate.